These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 408838)

  • 1. Plasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment.
    Hansen LB; Larsen NE
    Psychopharmacology (Berl); 1977 Jul; 53(2):127-30. PubMed ID: 408838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of perphenazine (Trilafon) related to development of extrapyramidal side effects.
    Hansen LB; Larsen NE; Vestergård P
    Psychopharmacology (Berl); 1981; 74(4):306-9. PubMed ID: 6794071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of perphenazine and its major metabolites during simultaneous treatment with anticholinergic drugs.
    Hansen LB; Elley J; Christensen TR; Larsen NE; Naestoft J; Hvidberg EF
    Br J Clin Pharmacol; 1979 Jan; 7(1):75-80. PubMed ID: 760745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of perphenazine and its sulphoxide metabolite in human plasma after therapeutic doses by gas chromatography.
    Larsen NE; Naestoft J
    J Chromatogr; 1975 Jun; 109(2):259-64. PubMed ID: 1150819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetic studies of perphenazine.
    Eggert Hansen C; Rosted Christensen T; Elley J; Bolvig Hansen L; Kragh-Sorensen P; Larsen NE; Naestoft J; Hvidberg EF
    Br J Clin Pharmacol; 1976 Oct; 3(5):915-23. PubMed ID: 973987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of perphenazine and its metabolites in plasma by high-performance liquid chromatography and coulometric detection.
    Foglia JP; Sorisio D; Kirshner MA; Mulsant BH; Perel JM
    J Chromatogr B Biomed Appl; 1995 Jun; 668(2):291-7. PubMed ID: 7581864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perphenazine serum levels in patients on standard doses.
    Haffner F
    Psychopharmacol Ser; 1989; 7():280-3. PubMed ID: 2687863
    [No Abstract]   [Full Text] [Related]  

  • 8. Perphenazine concentrations in human whole blood. A pilot study during anti-psychotic therapy using different administration forms.
    Hansen CE; Larsen NE
    Psychopharmacologia; 1974 Jun; 37(1):31-6. PubMed ID: 4415024
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic advantages of monitoring plasma concentrations of perphenazine in clinical practice.
    Hansen LB; Larsen NE
    Psychopharmacology (Berl); 1985; 87(1):16-9. PubMed ID: 3933033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response relationships of perphenazine in the treatment of acute psychoses.
    Hansen LB; Larsen NE; Gulmann N
    Psychopharmacology (Berl); 1982; 78(2):112-5. PubMed ID: 6817364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the optimal perphenazine decanoate dose based on blood samples drawn within the first three weeks.
    Larsen NE; Hansen LB
    Ther Drug Monit; 1989 Nov; 11(6):642-6. PubMed ID: 2595744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects.
    Mazure CM; Nelson JC; Jatlow PI; Kincare P; Bowers MB
    J Clin Psychiatry; 1990 Aug; 51(8):330-4. PubMed ID: 2199431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas chromatographic determination of amitriptyline, nortriptyline and perphenazine in plasma of schizophrenic patients after administration of the combination of amitriptyline with perphenazine.
    Cooper S; Albert JM; Dugal R; Bertrand M; Elie R
    Arzneimittelforschung; 1979; 29(1):158-61. PubMed ID: 582110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abscesses following prolonged intramuscular administration of perphenazine enantate.
    Starmark JE; Forsman A; Wahlström
    Acta Psychiatr Scand; 1980 Aug; 62(2):154-7. PubMed ID: 6110312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between perphenazine plasma levels and clinical response in acute schizophrenia.
    Omérov M; Wistedt B; Bolvig-Hansen L; Larsen NE
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):159-66. PubMed ID: 2664884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zuclopenthixol and perphenazine in patients with acute psychotic states. A double-blind multicentre study.
    Remvig J; Larsen H; Rask P; Skausig OB; Skov S; Strömgren LS
    Pharmacopsychiatry; 1987 Jul; 20(4):147-54. PubMed ID: 3615572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of perphenazine in psychiatric emergencies: the concept of chemical restraint.
    Fann WE; Linton PH
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):478-82. PubMed ID: 4629310
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy control of perphenazine. 2. Clinical aspects].
    Kjeldsen CS; Larsen NE; Kragh-Sørensen P; Andersen E; Brøsen K; Gerholt F; Glue P; Hørder M; Klitgaard NA; Krarup G
    Ugeskr Laeger; 1991 Aug; 153(34):2339-43. PubMed ID: 1897043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perphenazine decanoate in sesame oil vs. perphenazine enanthate in sesame oil: a comparative study of pharmacokinetic properties and some clinical implications.
    Knudsen P; Hansen LB; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():11-4. PubMed ID: 3865500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of serum monitoring on concentration of perphenazine and zuclopenthixole].
    Thomsen K; Olesen OV; Poulsen JH
    Ugeskr Laeger; 1993 Aug; 155(32):2443-8. PubMed ID: 8356762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.